CVS Ex-Dividend Reminder - 4/19/13 Wednesday, April 17, 10:10 AM ET, by Market News Video Staff On 4/19/13, CVS Caremark Corporation (CVS) will trade ex-dividend, for its quarterly dividend of $0.225, ...
By Market News Video Staff, Tuesday, September 13, 10:08 AM ET
Health insurer Aetna (NYSE:AET) is watching its shares rise today after the company said it may exceed its full-year earnings forecast.
Aetna said in a regulatory filing that, based on its strong third quarter performance, it is now projecting full-year 2011 operating results will exceed its prior guidance for earnings of $4.60 to $4.70 per share.
The company said it will update its full year guidance in its third quarter earnings conference call.
Aetna made the disclosures ahead of a Morgan Stanley (NYSE:MS) healthcare conference today.
It also noted that in 2012, it projects that growth in its Medicare and large-group commercial risk businesses will partially offset projected commercial administrative services contract membership losses. It also plans on accretive impacts on earnings per share due to its agreement with CVS Caremark (NYSE:CVS) and its recent acquisitions in 2012.
Aetna shares are trading up 4.45% Tuesday.
Rival UnitedHealth (NYSE:UNH) is trading higher by 2.4% today, while Cigna (NYSE:CI) trades up 3.4%, and WellPoint (NYSE:WLP) trades higher by 3.25%.
This Article's Word Cloud:AetnaCaremarkMorganNYSETuesdayUnitedHealthWellPointacquisitionsafteragreementaheadalsobasedcallcommercialcompanyconferencecontractdisclosuresearningsexceedfilingfullgroupgrowthguidancehealthcarehigherimpactslargemembershippartiallyplansquarterrecentriserisksaidsharesharesthatthirdtodaytradestradingupdatewhilewillwithyear
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.